HRB National Drugs Library e-newsletter volume 18, issue 6

In this issue

Irish-related publications

International publications

« back to cover page

International publications

European drug report 2022: trends and developments.

EMCDDA (2022) Luxembourg: Publications Office of the European Union.

World drug report 2022.

(2022) Vienna: UNODC

Spotlight on... e-health interventions.

(2022) EMCDDA

EMCDDA webinar: Drug consumption rooms in Europe - different realities, challenges and what to expect in the future.

(2022) EMCDDA

EMCDDA webinar: Knowing youth — digital platforms for decision making (ESPAD and beyond).

(2022) EMCDDA

How to run a trends workshop: an EMCDDA foresight toolkit for the drugs field.

(2022) Lisbon: EMCDDA.

Reporting of substance media toolkit

(2022) Scottish Families Affected by Alcohol and Drugs, Adfam

Suspected drug deaths in Scotland: January to March 2022.

(2022) Edinburgh: Scottish Government

Risk of non-fatal suicide attempt in individuals with substance use disorder: the roles of aggregate genetic liability and environmental exposures in a Swedish population-based cohort.

Lannoy, Séverine et al (2022) Addiction, Early online. doi: 10.1111/add.15965

Mortality in the SuperMIX cohort of people who inject drugs in Melbourne, Australia: a prospective observational study.

Hill, Penelope L et al (2022) Addiction, Early online. doi: 10.1111/add.15975

High rates of resumption of injecting drug use following release from prison among men who injected drugs before imprisonment.

Curtis, Michael et al (2022) Addiction, Early online. doi: 10.1111/add.15971

Prevalence and self-rated health and depression of family members affected by addictive disorders: results of a nationwide cross-sectional study.

Bischof, G et al (2022) Addiction, Early online. doi: 10.1111/add.15960

Association of obsessive-compulsive disorder and obsessive-compulsive symptoms with substance misuse in 2 longitudinal cohorts in Sweden.

Virtanen, Suvi et al (2022) JAMA Network Open, 5, (6).

Guidance for local delivery partners. From harm to hope: A 10-year drugs plan to cut crime and save lives.

HM Government (2022) UK HM Government.

Factors influencing adherence to mHealth apps for prevention or management of noncommunicable diseases: systematic review.

Jakob, Robert et al (2022) Journal of Medical Internet Research, 24, (5). doi: 10.2196/35371

Pathways into, through and out of residential rehabilitation in Scotland: Interviews with people with lived experience of accessing residential rehabilitation.

(2022) Edinburgh: Scottish Government

An approximation to the identification of contexts, experiences, and profiles of victims of drug-facilitated sexual assaults.

Prego-Meleiro, Pablo et al (2022) Journal of Forensic and Legal Medicine, 90.

Sex differences in substance use, prevalence, pharmacological therapy, and mental health in adolescents with attention-deficit/hyperactivity disorder (ADHD).

Castellano-García, Francisca et al (2022) Brain Sciences, 12, (5).

General Report of Activities 2021 – key achievements and governance: a year in review.

EMCDDA (2022) Luxembourg: Publications Office of the European Union.

Monitoring drug use in the digital age: studies in web surveys.

(2022) Lisbon: EMCDDA

Causal inference with observational data in addiction research.

Chan, Gary C K et al (2022) Addiction, Early online. doi: 10.1111/add.15972

We are the researched, the researchers, and the discounted: the experiences of drug user activists as researchers.

(2021) The International Journal on Drug Policy, 98.

New psychoactive substances: 25 years of early warning and response in Europe. An update from the EU Early Warning System.

EMCDDA (2022) Luxembourg: Publications Office of the European Union.

N-Cyclohexyl Butylone.

(2022) Pennsylvania: Center for Forensic Science Research & Education.

Krotulski, Alex J et al (2022) Pennsylvania: Center for Forensic Science Research and Education.

Detection of the synthetic cannabinoids AB-CHMINACA, ADB-CHMINACA, MDMB-CHMICA, and 5F-MDMB-PINACA in biological matrices: a systematic review.

Navarro-Tapia, Elisabet et al (2022) Biology, 11, (5). doi: 10.3390/biology11050796

Gabapentinoids: repeating mistakes of the past?

Murnion, Bridin et al (2022) Addiction, Early online. doi: 10.1111/add.15970

Substance use, health, and adverse life events amongst amphetamine-type stimulant users in North East England: a cross-sectional study.

Adams, Emma Audrey et al (2022) International Journal of Environmental Research and Public Health, 19, (12).

The Cathinone Hydra: increased cathinone and caffeine adulteration in the English MDMA market after Brexit and COVID-19 lockdowns.

Pascoe, Michael J et al (2022) Drug Science, Policy and Law, 8.

Pediatric melatonin ingestions - United States, 2012-2021.

Lelak, Karima et al (2022) Morbidity and Mortality Weekly Report, 71, (22), pp. 725-729

Alternative options for complex, recurrent pain states using cannabinoids, psilocybin, and ketamine: a narrative review of clinical evidence.

Edinoff, Amber N et al (2022) Neurology International, 14, (2), pp. 423-436.

National benchmarking report on implementation of the Medication Assisted Treatment (MAT) standards. 2021/22.

(2022) Edinburgh: Public Health Scotland.

What is the prevalence of and trend in opioid use disorder in the United States from 2010 to 2019? Using multiplier approaches to estimate prevalence for an unknown population size.

Keyes, Katherine M et al (2022) Drug and Alcohol Dependence Reports, 3.

Association of opioid use disorder with healthcare utilization and cost in a public health system.

Miron, Oren et al (2022) Addiction, Early online. doi: 10.1111/add.15963

ACMD review of the UK naloxone implementation.

(2022) London: Advisory Council on the Misuse of Drugs

Take-home drug checking as a novel harm reduction strategy in British Columbia, Canada.

Klaire, Sukhpreet et al (2022) International Journal on Drug Policy, 106. doi: 10.1016/j.drugpo.2022.103741

Long-term risk of overdose or mental health crisis after opioid dose tapering.

Fenton, Joshua J et al (2022) JAMA Network Open, 5, (6).

Analysis of urine drug test results from substance use disorder treatment practices and overdose mortality rates, 2013-2020.

Whitley, Penn et al (2022) JAMA Network Open, 5, (6).

The inclusion of patients' reported outcomes to inform treatment effectiveness measures in opioid use disorder. a systematic review.

Sanger, Nitika et al (2022) Patient Related Outcome Measures, 13. pp. 113-130.

Changes in the development of opioid tolerance on re-exposure among people who use heroin: a qualitative study.

Kesten, Joanna May et al (2022) PloS one, 17, (6).

Becoming our young people's case managers: caregivers' experiences, needs, and ideas for improving opioid use treatments for young people using opioids.

Marchand, Kirsten et al (2022) Substance Abuse Treatment, Prevention, and Policy, 17.

Integrated care model and point of care diagnostics facilitate Hepatitis C treatment among patients receiving opioid agonist therapy: a retrospective review of medical records.

Häkkinen, Margareeta et al (2022) Substance Abuse Treatment, Prevention, and Policy, 17, (1).

Impact of reduced restrictions on buprenorphine prescribing during COVID-19 among patients in a community-based treatment program.

Ward, Kathleen M et al (2022) Drug and Alcohol Dependence Reports, 3

Cannabis legalization: 2021–2022 observations.

(2022) Ottawa: Canadian Centre on Substance Use and Addiction.

Changes in youth cannabis use after an increase in cannabis minimum legal age in Quebec, Canada.

Nguyen, Hai V and Mital, Shweta (2022) JAMA Network Open, 5, (6).

Age-period-cohort analysis of trends in tobacco smoking, cannabis use, and their co-use in the Australian population.

Leung, Janni et al (2022) Addiction, Early online. doi: 10.1111/add.15951

Cannabis use and risks of respiratory and all-cause morbidity and mortality: a population-based, data-linkage, cohort study.

Vozoris, Nicholas T et al (2022) BMJ Open Respiratory Research, 9, (1).

The effectiveness of cannabis and cannabis derivatives in treating lower back pain in the aged population: a systematic review.

Senderovich, Helen et al (2022) Gerontology, 68, (6), pp. 612-624.

Trends in cannabis polysubstance use during early pregnancy among patients in a large health care system in Northern California.

Young-Wolff, Kelly C et al (2022) JAMA Network Open, 5, (6).

Cannabis-based products for chronic pain: a systematic review.

McDonagh, Marian S et al (2022) Annals of Internal Medicine, Early online. doi: 10.7326/M21-4520

Monitoring and Evaluating Scotland’s Alcohol Strategy (MESAS): monitoring report 2022.

Ponce Hardy, Vicki and Giles, Lucie (2022) Edinburgh: Public Health Scotland.

Evaluating the impact of Minimum Unit Pricing in Scotland on people who are drinking at harmful levels.

Holmes, John et al (2022) Edinburgh: Public Health Scotland.

Contents unknown: how alcohol labelling still fails consumers.

(2022) London: Alcohol Health Alliance UK.

Impact of health warning labels on selection and consumption of food and alcohol products: systematic review with meta-analysis.

Clarke, Natasha et al (2021) Health Psychology Review, 15, (3), pp. 430-453.

The impact of social workers in cirrhosis care: a systematic review.

Ufere, Nneka N et al (2022) Current Treatment Options in Gastroenterology, 20, (2), pp. 160-176.

Review of alcohol marketing restrictions in seven European countries

Scobie, Graeme et al (2022) Glasgow: Public Health Scotland.

The impact of alcohol priming on craving and motivation to drink: a meta-analysis.

Halsall, Lauren et al (2022) Addiction, Early online. doi: 10.1111/add.15962

Alcohol-related liver disease.

British Liver Trust (2022)

Alcohol-related liver disease mortality and missed opportunities in secondary care: A United Kingdom retrospective observational study.

Subhani, Mohsan et al (2022) Drugs and Alcohol Review, Early online.

Alcohol use disorder: neurobiology and therapeutics.

Yang, Waisley et al (2022) Biomedicines, 10, (5).

Validating transdermal alcohol biosensors: a meta-analysis of associations between blood/breath-based measures and transdermal alcohol sensor output.

Yu, Jiachen et al (2022) Addiction, Early online. doi: 10.1111/add.15953

Meta-analysis of associations between empathy and alcohol use and problems in clinical and non-clinical samples.

Kumar, Lakshmi et al (2022) Addiction, Early online. doi: 10.1111/add.15941

Theta oscillatory dynamics of inhibitory control, error processing, and post-error adjustments: Neural underpinnings and alcohol-induced dysregulation.

Marinkovic, Ksenija and Rosen, Burke Q (2022) Alcoholism, Clinical and Experimental Research, Early online. doi: 10.1111/acer.14856

Characterising smoking and smoking cessation attempts by risk of alcohol dependence: a representative, cross-sectional study of adults in England between 2014-2021.

Garnett, Claire et al (2022) The Lancet Regional Health - Europe, Early online. https://doi.org/10.1016/j.lanepe.2022.100418

Public mental health and smoking. A framework for action.

(2022) London: ASH and Public Mental Health Implementation Centre.

The Khan review: making smoking obsolete.

Khan, Javad (2022) London: Office for Health Improvement and Disparities.

Service user perceptions of smoking cessation in residential substance use treatment.

Swithenbank, Zoe et al (2022) PLoS ONE, 17, (6).

“Surviving, not living”: lived experiences of crime and gambling.

Smith, Lauren (2022) London: Commission on Crime and Gambling Related Harms.

Police awareness and practice regarding gambling related harms.

Churcher, Helen (2022) London: Commission on Crime and Gambling Related Harms.

Safer gambling and consumer protection failings amongst 40 frequently visited cryptocurrency-based online gambling operators.

Andrade, Maira et al (2022) PsyArXiv, https://doi.org/10.31234/osf.io/fgxrb

Copyright © 2022 HRB National Drugs Library. All rights reserved.

The HRB National Drugs Library newsletter is a free subscriber-only monthly email newsletter offering relevant Irish and international news and information on alcohol and other drugs research. E-mail addresses provided for the purpose of subscribing to the newsletter will only be used by the library to distribute the requested information. The newsletter is published by the HRB National Drugs Library, Health Research Board. The library is staffed by qualified information professionals who handle a wide range of enquiries. Not sure what we can do for you? Email us and we will be happy to discuss your information needs.